Related Experiment Videos
Radioiodinated 1-substituted-4-phenylpiperazines as potential brain imaging agents
International Journal of Nuclear Medicine and Biology
|January 1, 1985
Summary
Researchers developed novel 125I-labeled 1-substituted-4-phenylpiperazines for brain imaging. A butyrophenone derivative showed promising brain retention and high brain-to-blood ratios in rats, suitable for SPECT imaging.
Area of Science:
- Radiochemistry
- Neuroimaging
- Pharmacology
Background:
- Development of novel radiotracers is crucial for advancing brain imaging techniques.
- 1-substituted-4-phenylpiperazines are a class of compounds with potential for central nervous system targeting.
Purpose of the Study:
- To synthesize and evaluate 125I-labeled 1-substituted-4-phenylpiperazines as potential brain imaging agents.
- To determine the optimal compound for in vivo brain imaging applications.
Main Methods:
- Synthesis of four 125I-labeled 1-substituted-4-phenylpiperazines using [125I]iodide/chloramine-T or iodine monochloride.
- Radiochemical isolation in 48-60% yields.
- Tissue distribution studies in rats over a 4-hour period.
Main Results:
- A butyrophenone derivative exhibited superior brain imaging properties.
- This derivative demonstrated prolonged brain retention and higher brain-to-blood ratios compared to other analogs.
- In vivo behavior was comparable to radioiodinated N-isopropyl-p-iodoamphetamine.
Conclusions:
- The butyrophenone derivative shows significant potential as a brain imaging agent for single photon emission computed tomography (SPECT).
- Direct labeling via electrophilic methods enhances its utility for clinical applications.